SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-199083
Filing Date
2019-07-22
Accepted
2019-07-22 17:15:56
Documents
5
Period of Report
2019-07-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d781708d8k.htm 8-K 25030
2 EX-1.1 d781708dex11.htm EX-1.1 232687
3 EX-4.1 d781708dex41.htm EX-4.1 62575
4 EX-5.1 d781708dex51.htm EX-5.1 13621
5 GRAPHIC g781708781708.jpg GRAPHIC 7843
  Complete submission text file 0001193125-19-199083.txt   345969
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 19966364
SIC: 2836 Biological Products, (No Diagnostic Substances)